Tetrahydropyran (THP)-substituted bicyclic-pyrimidinedione compounds

MYPI2025001954A0Undetermined Publication Date: 2020-04-29MYOKARDIA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025001954
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-10-29
Filing Date
2019-10-28
Publication Date
2020-04-29
Patent Text Reader

Abstract

The present disclosure provides novel tetrahydropyran (THP)-substituted bicyclic pyrimidinedione compounds that are useful for the treatment of hypertrophic cardiomyopathy (HCM), conditions associated with left ventricular hypertrophy, conditions associated with diastolic dysfunction, and / or symptoms associated thereof. The synthesis and characterization of the compounds is described, as well as methods for treating HCM and other forms of heart disease.
Need to check novelty before this filing date? Find Prior Art